The Precision Health Initiative is conducted by Genuity Science. Learn more about our recent restructure here.

Liver Diseases
NASH & NAFLD

Find out more about Genuity's Liver Disease NASH & NAFLD study

It is believed that 20-30% of the general population in Ireland has NAFLD (nonalcoholic fatty liver disease) and it is estimated that up to 70% of Type 2 Diabetes patients may also have the disease. Of those patients with NAFLD, it is estimated 20% will develop NASH (nonalcoholic steatohepatitis). NASH and NAFLD occur in the absence of high alcohol intake, making it different than liver disease caused by excessive alcoholic consumption.

Register your interest below for our study

If you would like to know more about Genuity’s Liver Diseases NASH & NAFLD study please complete the form below. Genuity will use this information to:

  • Notify you if a Genuity study site opens up in the hospital site and/or county you have indicated
  • Use consultant and/or hospital site information to build metrics to help us better understand geographic demand for new study sites
  • Keep you informed of Genuity news if you elect to sign up to receive general news on Genuity Science

Register your interest below for our study

If you would like to know more about Genuity’s Liver Diseases (NASH and NAFLD) study please complete the form below.

All fields with exception of first name and email address are optional.

Related Videos

What is Genomics?
Genuity Research Participation Overview
The Journey of a Blood Sample
Genuity Science Data Privacy